enting. Among the 157 patients
treated initially, 57 (36%) developed recurrent stenosis
at a mean follow-up of 29 months with 24 patients
(42%) with recurrent stenoses developing recurrent
symptoms (CMI, 21; AMI, 3). Repeat endovascular treatment was possible in 26 (87%) and was associate with
low mortality (3%) and excellent symptom improvement